Vivos Therapeutics, Inc. VVOS
0.11 USD 0.00 (+1.39%)
At closeNov 3, 2026, 7:17 PM EST
0.11 0.00 +4.19%
After hours · Nov 3, 7:17 PM ET
0.1063 Day range 0.1124
0.1063 52-week range 2.72
- YTD
- -94.59%
- 1 year
- -95.55%
Analyst view
Price target (mean) 6.30 +5637.7% upside
Now 0.1098
- Target (low)
- 6.00
- Target (mean)
- 6.30
- Target (high)
- 6.60
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.43 | -0.43 – -0.43 | -2.76 | +84.4% | 3.89M | +19.6% | 1 |
| Next quarter | -0.41 | -0.41 – -0.41 | -1.63 | +74.9% | 4.10M | +19.9% | 1 |
| Current year | -1.79 | -1.79 – -1.79 | -14.24 | +87.4% | 15.20M | +10.2% | 1 |
| Next year | -1.43 | -1.43 – -1.43 | -1.79 | +20.1% | 19.16M | +26.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 20, 2024 | Ascendiant Capital | Reiterated | Buy | Buy |
| Nov 19, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Aug 20, 2024 | Ascendiant Capital | Maintained | Buy | Buy |